ArriVent Biopharma Launches with Up To $150M in Series A Financing and Strategic Licensing Agreement for Clinical-Stage Oncology Asset

Amy Giles
Increasing Engagement

Daniel Sontupe
Market Access

Paul Theisen
Patient Acquisition

Brenda Snow
Authentic Patient Voice

Suma Ramadas, PhD
Medical Affairs

Frank Burrell
Scientific Storytelling

Matthew Durham
Omnidynamic Marketing

Stacey Gandler
Brand Nourishment

Pat Purcell
Meeting Engagement

Liz Kane
Impactful Strategy

Joey Cohen
Medication Adherence

Matt Turner
Patient Affordability

David Linetsky
Point-of-Care Marketing

Bud Bilanich
Success Coach